Catalent Signs Agreement with J&J to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate Read more
Challenges in Supply and Partner-Sourcing for Stem-Gene – Clinical Trial Supply – A Virtual Experience Read more
Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm Read more
Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs License for Promising Drug to Treat Bone Cancer Read more
Pneumagen Ltd Announces Positive Anti-Viral Activity for Novel Glycan Approach in Preventing Coronavirus (COVID-19) Infections Read more
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data For Stro-002 Antibody-Drug Conjugate In Ovarian Cancer Read more